Author

Brigida Barberio

COMPARATIVE ASSESSMENT OF INFLIXIMAB TROUGH LEVELS BETWEEN POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (ENZYME LINKED IMMUNOSORBENT ASSAY) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
COMPARATIVE ASSESSMENT OF INFLIXIMAB TROUGH LEVELS BETWEEN POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (ENZYME LINKED IMMUNOSORBENT ASSAY) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

COMPARISON OF MEDICAL THERAPIES FOR NON-EROSIVE REFLUX DISEASE: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
COMPARISON OF MEDICAL THERAPIES FOR NON-EROSIVE REFLUX DISEASE: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

Brigida Barberio  et al.

A SPECIFIC MICROBIOTA SIGNATURE IS ASSOCIATED TO IMMUNOTHERAPY-RELATED COLITIS AS ASSESSED BY A MACHINE LEARNING APPROACH – A COMPARATIVE STUDY WITH INFLAMMATORY BOWEL DISEASES AND HEALTHY CONTROLS
A SPECIFIC MICROBIOTA SIGNATURE IS ASSOCIATED TO IMMUNOTHERAPY-RELATED COLITIS AS ASSESSED BY A MACHINE LEARNING APPROACH – A COMPARATIVE STUDY WITH INFLAMMATORY BOWEL DISEASES AND HEALTHY CONTROLS

Brigida Barberio  et al.

NATURAL HISTORY AND IMPACT OF IRRITABLE BOWEL SYNDROME-TYPE SYMPTOMS IN INFLAMMATORY BOWEL DISEASE DURING ONE-YEAR OF LONGITUDINAL FOLLOW UP
NATURAL HISTORY AND IMPACT OF IRRITABLE BOWEL SYNDROME-TYPE SYMPTOMS IN INFLAMMATORY BOWEL DISEASE DURING ONE-YEAR OF LONGITUDINAL FOLLOW UP

Brigida Barberio  et al.

TISSUE MICRO-RNAS AS MARKERS OF EARLY DIAGNOSIS AND MONITORING OF COLORECTAL CANCER IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
TISSUE MICRO-RNAS AS MARKERS OF EARLY DIAGNOSIS AND MONITORING OF COLORECTAL CANCER IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Brigida Barberio  et al.

ENTERIC INFECTIONS WORSEN POST DISCHARGE OUTCOMES IN PATIENTS HOSPITALIZED FOR INFLAMMATORY BOWEL DISEASE FLARE: A SINGLE CENTER STUDY.
ENTERIC INFECTIONS WORSEN POST DISCHARGE OUTCOMES IN PATIENTS HOSPITALIZED FOR INFLAMMATORY BOWEL DISEASE FLARE: A SINGLE CENTER STUDY.

Brigida Barberio  et al.

EOSINOPHILIC ESOPHAGITIS IS FREQUENTLY ASSOCIATED WITH DISORDERS OF PERISTALSIS AT HIGH-RESOLUTION MANOMETRY: A PROSPECTIVE SINGLE-CENTRE CASE-CONTROL STUDY
EOSINOPHILIC ESOPHAGITIS IS FREQUENTLY ASSOCIATED WITH DISORDERS OF PERISTALSIS AT HIGH-RESOLUTION MANOMETRY: A PROSPECTIVE SINGLE-CENTRE CASE-CONTROL STUDY

Brigida Barberio  et al.

USTEKINUMAB TREATMENT IN CROHN’S DISEASE AND ULCERATIVE COLITIS: A REAL-WORLD COMPARISON BETWEEN ITS EFFECTIVENESS AND SAFETY IN THIS TWO POPULATIONS
USTEKINUMAB TREATMENT IN CROHN’S DISEASE AND ULCERATIVE COLITIS: A REAL-WORLD COMPARISON BETWEEN ITS EFFECTIVENESS AND SAFETY IN THIS TWO POPULATIONS

Brigida Barberio  et al.

COMPARISON OF DRUGS FOR EOSINOPHILIC ESOPHAGITIS: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
COMPARISON OF DRUGS FOR EOSINOPHILIC ESOPHAGITIS: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

Brigida Barberio  et al.

A MACHINE LEARNING APPROACH IDENTIFIES SPECIFIC MICROBIOTA SIGNATURE ASSOCIATED TO VARIOUS DEGREE OF ULCERATIVE COLITIS
A MACHINE LEARNING APPROACH IDENTIFIES SPECIFIC MICROBIOTA SIGNATURE ASSOCIATED TO VARIOUS DEGREE OF ULCERATIVE COLITIS

Brigida Barberio  et al.

COMPARATIVE ASSESSMENT OF INFLIXIMAB TROUGH LEVELS BETWEEN POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (ENZYME LINKED IMMUNOSORBENT ASSAY) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
COMPARATIVE ASSESSMENT OF INFLIXIMAB TROUGH LEVELS BETWEEN POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (ENZYME LINKED IMMUNOSORBENT ASSAY) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Brigida Barberio  et al.

ARTIFICIAL INTELLIGENCE IN THE DIAGNOSIS OF ESOPHAGEAL DISEASES: A SYSTEMATIC REVIEW WITH META-ANALYSIS
ARTIFICIAL INTELLIGENCE IN THE DIAGNOSIS OF ESOPHAGEAL DISEASES: A SYSTEMATIC REVIEW WITH META-ANALYSIS

Brigida Barberio  et al.

THE ANTI IL-23/IL-12 AGENT USTEKINUMAB IS AN EFFECTIVE AND SAFE INDUCTION THERAPY IN PATIENTS WITH CROHN'S DISEASE REFRACTORY OR INTOLERANT TO ANTI-TNF: A MULTICENTRE ITALIAN STUDY
THE ANTI IL-23/IL-12 AGENT USTEKINUMAB IS AN EFFECTIVE AND SAFE INDUCTION THERAPY IN PATIENTS WITH CROHN'S DISEASE REFRACTORY OR INTOLERANT TO ANTI-TNF: A MULTICENTRE ITALIAN STUDY

Brigida Barberio  et al.

SWITCHING FROM ADALIMUMAB ORIGINATOR TO ABP 501 BIOSIMILAR: A MULTICENTRIC NORTH ITALIAN STUDY
SWITCHING FROM ADALIMUMAB ORIGINATOR TO ABP 501 BIOSIMILAR: A MULTICENTRIC NORTH ITALIAN STUDY

Brigida Barberio  et al.

LONG-TERM TREATMENT WITH PROTON PUMP INHIBITORS AND TOPICAL STEROIDS IN EOSINOPHILIC ESOPHAGITIS: EFFICACY AND FACTORS INFLUENCING RESPONSE
LONG-TERM TREATMENT WITH PROTON PUMP INHIBITORS AND TOPICAL STEROIDS IN EOSINOPHILIC ESOPHAGITIS: EFFICACY AND FACTORS INFLUENCING RESPONSE

Brigida Barberio  et al.

RISK FACTORS OF MALIGNANCIES IN INFLAMMATORY BOWEL DISEASE: A SINGLE CENTER EXPERIENCE
RISK FACTORS OF MALIGNANCIES IN INFLAMMATORY BOWEL DISEASE: A SINGLE CENTER EXPERIENCE

Brigida Barberio  et al.

LARGE DIFFERENCES IN IBD CARE AND EDUCATION ACROSS EUROPE, FIRST RESULTS OF THE PAN-EUROPEAN VIPER SURVEY
LARGE DIFFERENCES IN IBD CARE AND EDUCATION ACROSS EUROPE, FIRST RESULTS OF THE PAN-EUROPEAN VIPER SURVEY

Brigida Barberio  et al.

SODIUM BUTYRATE SUPPLEMENTATION SIGNIFICANTLY IMPROVED CLINICAL OUTCOMES AND QUALITY OF LIFE IN PATIENTS WITH CROHN’S DISEASE – RESULTS FROM A RANDOMISED PLACEBO-CONTROLLED STUDY
SODIUM BUTYRATE SUPPLEMENTATION SIGNIFICANTLY IMPROVED CLINICAL OUTCOMES AND QUALITY OF LIFE IN PATIENTS WITH CROHN’S DISEASE – RESULTS FROM A RANDOMISED PLACEBO-CONTROLLED STUDY

Brigida Barberio  et al.

COMPARATIVE ASSESSMENT C-REACTIVE PROTEIN BETWEEN A POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (IMMUNONEPHELOMETRIC TESTING)
COMPARATIVE ASSESSMENT C-REACTIVE PROTEIN BETWEEN A POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (IMMUNONEPHELOMETRIC TESTING)

Brigida Barberio  et al.

IMPACT OF TWO DIFFERENT TRANSITION PROGRAMS ON TRANSITION READINESS AND QUALITY OF LIFE: A RANDOMISED CONTROLLED TRIAL IN INFLAMMATORY BOWEL DISEASE
IMPACT OF TWO DIFFERENT TRANSITION PROGRAMS ON TRANSITION READINESS AND QUALITY OF LIFE: A RANDOMISED CONTROLLED TRIAL IN INFLAMMATORY BOWEL DISEASE

Brigida Barberio  et al.

Item 1 - 20 / 26
1
2